[Source](https://github.com/mm80843/T3.5/blob/main/docs/index.md) -- [Risk](https://github.com/mm80843/T3.5/tree/main/docs/Risk/index.md) 

# Risk: __Lack of access to pharmaceutical interventions__ (PBN__Risk_1158)

## Property: has_RiskHealth

* [physical](https://github.com/mm80843/T3.5/blob/main/docs/RiskHealth/PBN__RiskHealth_0.md)

## List of stakeholders linked to the risk

* [governments](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_47.md)
* [pharmaceutical companies](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_124.md)
* [international organizations](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_242.md)

## Property: has_RiskISO_Purpose

* [Attractiveness](https://github.com/mm80843/T3.5/blob/main/docs/RiskISO/PBN__RiskISO_Impact_9.md)

## Articles mentionning the risk

* [bauerle_e-mental_2020](https://github.com/mm80843/T3.5/blob/main/docs/Article/PBN__Article_209.md)

## Property: has_RiskDescription

Developing countries may not have timely access to antiviral medicines and vaccines

## People affected by this risk

* [developing countries](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_223.md)

## Technologies linked to the risk


## Property: has_RiskType

* [technological](https://github.com/mm80843/T3.5/blob/main/docs/RiskType/PBN__RiskType_5.md)

## Property: has_RiskISO_Impact

* [Biodiversity and ecosystem services](https://github.com/mm80843/T3.5/blob/main/docs/RiskISO/PBN__RiskISO_Purpose_4.md)

## Name of the risk

Higher morbidity and mortality rates in affected populations

## Mitigations of this risk

* [Focus on non-pharmaceutical interventions, prioritize distribution to countries in need](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_1610.md)

## Property: has_RiskGBN

* [No](https://github.com/mm80843/T3.5/blob/main/docs/RiskGBN/PBN__RiskGBN_0.md)

